Aptar Digital Health provides pharmaceutical companies with personalized digital health solution recommendations based on a brief five‑question assessment. By analyzing factors such as drug status, regulatory plans, geography, and therapeutic area, they suggest options like digital patient support programs or regulated SaMD tools to enhance patient adherence and outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies often lack a clear, efficient process to identify and select appropriate digital health solutions that align with a drug’s market status, regulatory pathway, and target geography. This uncertainty can delay integration of digital tools that support patient adherence, symptom management, and overall treatment outcomes.
Solution
Aptar Digital Health offers an interactive, five‑question assessment that captures key attributes of a drug and its intended market. Based on the responses, the platform generates a personalized recommendation—such as a digital patient support program (PSP), a regulated software‑as‑a‑medical‑device (SaMD) solution, or a comprehensive disease‑management platform. The service leverages Aptar’s portfolio of companion apps, study and data services, and connected drug‑delivery devices, ensuring that the suggested digital layer is technically feasible, regulatory‑compliant, and tailored to the specified therapeutic area and geography. By streamlining the decision‑making process, the platform helps pharma partners accelerate digital integration, improve patient engagement, and enhance treatment outcomes.
Target Audience
Primary customers are pharmaceutical manufacturers and drug development teams seeking to add a digital component to their products, as well as commercial organizations planning patient support programs across global markets.
Features
- Five‑question questionnaire that captures drug status, development phase, regulatory classification, geographic focus, and therapeutic indication
- Automated recommendation engine that matches responses to the most suitable digital health offering (digital PSP, SaMD, or disease‑management platform)
- Access to Aptar’s suite of companion apps, study & data services, and connected drug‑delivery devices for rapid implementation
- Alignment with regulatory requirements (e.g., FDA, EMA) and market‑specific compliance considerations
- Expertise across multiple therapeutic areas, including neurology, oncology, respiratory, immunology, and others
- Cloud‑based analytics and reporting to monitor patient adherence, symptom control, and outcome metrics